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Tropical diseases remain a major cause of morbidity and mortality in developing countries. Although combined
health efforts brought about significant improvements over the past 20 years, communities in resource-constrained
settings lack the means of strengthening their environment in directions that would provide less favourable
conditions for pathogens. Still, the impact of infectious diseases is declining worldwide along with progress
made regarding responses to basic health problems and improving health services delivery to the most vulnerable
populations. The London Declaration on Neglected Tropical Diseases (NTDs), initiated by the World Health
Organization’s NTD roadmap, set out the path towards control and eventual elimination of several tropical
diseases by 2020, providing an impetus for local and regional disease elimination programmes. Tropical diseases are
often patchy and erratic, and there are differing priorities in resources-limited and endemic countries at various levels
of their public health systems. In order to identify and prioritize strategic research on elimination of tropical diseases,
the ‘First Forum on Surveillance-Response System Leading to Tropical Diseases Elimination’ was convened in Shanghai
in June 2012. Current strategies and the NTD roadmap were reviewed, followed by discussions on how to identify and
critically examine prevailing challenges and opportunities, including inter-sectoral collaboration and approaches for
elimination of several infectious, tropical diseases. A priority research agenda within a ‘One Health-One World’ frame of
global health was developed, including (i) the establishment of a platform for resource-sharing and effective
surveillance-response systems for Asia Pacific and Africa with an initial focus on elimination of lymphatic filariasis, mal-
aria and schistosomiasis; (ii) development of new strategies, tools and approaches, such as improved diagnostics and
antimalarial therapies; (iii) rigorous validation of surveillance-response systems; and (iv) designing pilot studies to
transfer Chinese experiences of successful surveillance-response systems to endemic countries with limited resources.
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unless otherwise stated.control and elimination, and efficient sustainable devel-
opment [1,2]. Tropical diseases, including the neglected
tropical diseases (NTDs), comprise a group of infectious
diseases primarily affecting the poorest segments of soci-
ety in the tropics and subtropics [3-5]. Although the
NTDs affect more than a billion people in the world, the
research community, policy makers, implementers and
other stakeholders have only recently embarked on asses-
sing and elucidating the micro-epidemiology involved in
the eventual elimination of these diseases [3,6-9]. The
smallpox and polio eradication programmes provide con-
vincing examples of the critical role played by a globally
organised approach in linking surveillance data to tar-
geted, swift and effective public health responses [10-12].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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port offered by the World Health Organization (WHO),
multilateral agencies, philanthropic organisations and a
host of new consortia to fight tropical diseases, the public
health burden and the challenges facing programmes to
achieve sustained control and ultimate elimination of the
major NTDs are still enormous [13,14]. It has been argued
that effective surveillance-response systems are a key fea-
ture of reliable information on the prevalence, incidence,
spatio-temporal distribution and burden of diseases, which,
in turn, is essential for prevention, control and elimination
[5]. Rapid responses to outbreaks and emergencies are crit-
ical to ascertain the effective realization of targets, as well
as consolidation of current achievements towards meeting
the Millennium Development Goals and the post-2015
agenda of sustainable development [9,15,16]. Operational
research defining surveillance-response strategies based on
local and contextual situations is urgently needed to iden-
tify and validate suitable research priorities with respect to
elimination and eradication scenarios [17-22].
The ‘First Forum on Surveillance-Response System Lead-
ing to Tropical Disease Elimination’ was held on June 16-
18, 2012 in Shanghai. The Forum was jointly supported by
the National Institute of Parasitic Diseases of the Chinese
Center for Disease Control and Prevention (NIPD/China
CDC), the Swiss Tropical and Public Health Institute (Swiss
TPH) and the WHO. The purpose was to share knowledge
and experiences pertaining to the control, prevention and
elimination of major tropical diseases and to discuss novel
approaches towards the establishment of integrated
surveillance-response platforms and networks to assist
these efforts. The Forum brought together scientists, public
health experts and health policy specialists to explore and
discuss promising surveillance-response systems with focus
on, but not limited to, malaria, schistosomiasis, lymphatic
filariasis and other NTDs. The participants in each session
were engaged in in-depth discussion on current challenges,
opportunities and measures to foster reliable effective
surveillance-response systems as the strategic key for
endemic countries moving towards disease elimination.
It was felt that the establishment of a conceptual frame-
work to design and implement surveillance-response sys-
tems is critical for the elimination of tropical diseases
including NTDs. Surveillance-response systems with regard
to infectious diseases of poverty have gained traction,
particularly in settings where health systems provide an in-
tegrated data repository capable of characterising disease
dynamics at multiple scales. Evaluating the impact of imple-
mented programme(s) and intervention(s) in public health
centres and health services on the population-level towards
prevention or control of tropical diseases would benefit by
a system for surveillance and response leading towards
maximum positive health outcomes. To summarise, the
two-fold objectives of this paper were: (i) to establish aplatform for resource-sharing and effective surveillance-
response systems for Asia Pacific and Africa with an initial
focus on elimination of lymphatic filariasis, malaria and
schistosomiasis; and (ii) to explore new strategies, with an
emphasis on improved and more sensitive diagnostics and
antimalarial therapies in elimination programmes.
China: moving from disease control to elimination
Before 1955, just after the founding of the People’s Republic
of China, many infectious diseases were highly endemic,
particularly in the southern parts of the country, similar to
the epidemic and pandemic documented in Africa between
1980s and 2000 [19]. The devastating impact of schisto-
somiasis is made explicit by the line in one of the poems by
Chairman Mao Zedong: “Hundreds of villages overgrown
with weeds, sick people shitting and thousands of desolate
house-ghosts singing”, written in 1958. The epidemiological
characteristics of schistosomiasis transmission demanded a
well-structured and effective control programme put in
place long before the new phase of social and economic de-
velopment could gain foothold. By the end of 2011, 130 out
of the initially 454 endemic counties in 12 provinces
reached the criteria of transmission control and 274 had
interrupted transmission completely. In parallel, the num-
ber of individuals infected with Schistosoma japonicum had
declined to an all-time low with less than 300,000 infected
people [23,24].
With regard to malaria, it must be noted that sustained
efforts have reined in the endemic areas, which are now
considerably smaller with the number of cases in China de-
creasing from an estimated 30 million in the 1940s to less
than 5,000 by the end of 2011 [25]. Today, Plasmodium fal-
ciparum malaria has been eliminated as a public health
threat in all provinces except Yunnan. Among the 24
malaria-endemic provinces, annual incidence rates have
dropped below 1 per 10,000 in 95% of the endemic counties,
and only 87 counties have a rate above this threshold
[4,26,27]. Hence, in 2010, the Chinese Government decided
to embark on malaria elimination by 2015, with the excep-
tion of Yunnan province, and to completely interrupt trans-
mission across the country by 2020. Progress is monitored
through a dynamic infectious disease reporting system that
rigorously conducts case detection, collects and manages
information covering the entire country, including all town-
ships and counties where malaria is, or was, endemic
[27-30].
Knowledge on the unrelenting control of its many en-
demic tropical diseases and the growing expertise in
other disease-endemic regions of the world has shown
that China can harness evidence-based knowledge and
information, create innovative approaches and imple-
ment large-scale, effective solution for both its own
people and the global community. The low-level trans-
mission patterns of infection and re-infection rates in
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tinuing control activities are critical for ultimate success
of schistosomiasis and malaria surveillance-response sys-
tems. For example, transmission features in schistosomia-
sis include environmental contamination by eggs excreted
by a large number of domestic and wild animal species
that contribute to transmission; indeed the proportion of
eggs from water buffaloes might account for up to 90% of
all eggs found in the endemic areas [31,32]. In addition,
transmission interruption of schistosomiasis would be
marginal without this contribution. Hence, the current
schistosomiasis control strategy in China places particular
emphasis on the mechanisation of agriculture as this
would reduce the number of water buffaloes substantially
[33,34]. Evaluation of the new integrated control strategy
carried out in 26 villages in six townships of four counties
in four provinces (including the use of mollusciciding and
innovative educational methods, geospatial mapping of
hotspots, reservoir control through larval source manage-
ment using larvicides, environmental management, snail
control and mass drug administration (MDA) using prazi-
quantel) curbed the human infection to 0-1% after three
transmission seasons post-intervention. After four trans-
mission seasons post-intervention, the intermediate host
snail infection rate and the infection rate in sentinel mice
were reduced to zero. Long-term monitoring has shown
that it is possible to sustain the effectiveness of this strat-
egy [5,32,35].
Active case prevention and management with
regard to elimination
It was documented that active mapping of disease trans-
mission hotspots and molecular characterization of gen-
etic diversity and population dynamics were effective for
early detection, allowing prompt treatment using safe
and efficacious drugs. Meanwhile, patient compliance
and adherence to any effective prescribed regimen is
vital for public health management in primary healthcare
and minimising the evolution of resistant parasite strains
resulting from sub-therapeutic doses and drug selective
pressure indicators. There is a pressing need to develop
new surveillance tools and strategic responses to shift
the focus from control to elimination. With regard to
local elimination of malaria in China, specific response
packages must be tailored for different settings [36]. For
example, malaria in Hainan province is characterised by
imported cases whereas in Hunan province and along
the border between Yunnan province and Myanmar,
active P. vivax transmission and mixed infections with
P. falciparum and P. vivax are documented, respect-
ively [36,37].
Highly sensitive and specific diagnostic tools (e.g. sim-
ple, inexpensive and field-applicable molecular detection
devices) are urgently needed to target mass screening ofasymptomatic gametocyte reservoirs in low/moderate
endemic areas as well as sub-microscopic parasitaemia
and intensive integrated management of hotspots linked
to environmental, climatic and ecological appropriate-
ness for Anopheles vectors and transmission [36,38]. In-
tensification of the use of intermittent preventive treatment
(IPT) in high-risk groups (e.g. young children and pregnant
women in endemic-prone areas) and rigorous malaria
surveillance-response systems are necessary for effective
case management and follow-up. A policy for imported
cases should be developed and implemented nationwide,
placing particular emphasis on the local context and trans-
boundary migrant populations [39]. Additionally, research
on vector control in disease elimination was recommended,
particularly integrated vector management and the devel-
opment of new insecticides with low toxicity to humans
and the environment. Furthermore, additional funding re-
invigorating transmission-blocking vaccines targeting the
liver and/or gametocyte stages of the parasite would be
important [17,18].
New reliable tools and efficient strategies against other
communicable diseases were discussed, such as develop-
ment of highly sensitive diagnostic assays for early detec-
tion of low-transmission settings, MDA, development
and validation of vaccines for prevention and drugs for
management, improvement of preventive strategies and
environmental sanitation, information, education and com-
munication (IEC), community participation and ownership,
mechanisation of agriculture, sewage drainage, building of
public latrines, waste management and provision of clean
water as well as modelling based on a minimal essential
database approach (Table 1).
Implementation of Health in surveillance-response
systems
Health system and health policy makers, and government
will require development and implementation of new
surveillance-response system policies in the context of
infectious diseases elimination towards eradication (e.g.
containment of private-sector workers importing parasitic
diseases). New policies will include prevention and control,
community-based mobilisation, IEC as well as participation
and cooperation to re-enforce management, community
ownership and development, such as mechanisation of
agriculture and food production. For example, in malaria
information system, remote sensing, web-based infor-
mation, eHealth (healthcare supported by electronic
management and communication) and mHealth (mobile
health, that has emerged as a sub-segment of eHealth, the
use of information and communication technology (ICT)
for health services, information and communication) have
proved useful in controlling malaria in remote areas and
enhancing active surveillance as well as new and fast
ways of gathering geographical, spatial, ecological and
Table 1 Intervention tools for the elimination of targeted diseases
Intervention tools Targeted diseases
Mass drug administration (MDA) Malaria, schistosomiasis, lymphatic filariasis and other NTDs
Information, education and communication (IEC) Malaria, schistosomiasis, lymphatic filariasis and other NTDs
Community participation and ownership Malaria, schistosomiasis, lymphatic filariasis and other NTDs
Development of highly sensitive diagnostic assays for early detection of
low transmission settings
Malaria, schistosomiasis, lymphatic filariasis and other NTDs
Mechanisation of agriculture Schistosomiasis and other NTDs
Development and validation of vaccines for prevention and drugs for
prevention and management
Malaria, schistosomiasis, lymphatic filariasis and other NTDs
Improvement of preventive strategies and environmental sanitation Schistosomiasis and other NTDs
Sewage drainage Schistosomiasis and other NTDs
Public latrines Schistosomiasis and other NTDs
Waste management and provision of clean water Malaria, schistosomiasis, lymphatic filariasis and other NTDs
Mathematical modelling using a minimal essential database approach Malaria, schistosomiasis, lymphatic filariasis and other NTDs
Tambo et al. Infectious Diseases of Poverty 2014, 3:17 Page 4 of 10
http://www.idpjournal.com/content/3/1/17meteorological data relevant for the understanding of
foci of vector transmission, dynamics mapping for pa-
tient follow-up, containment of infections or outbreaks
and monitoring resistance [40-43].
In schistosomiasis, veterinary public health and emphasis
on the socioeconomic importance of zoonoses are needed
along with health education with special reference to farm-
ing and the development of a new policy for surveillance-
response systems to contain outbreaks and resurgence. In
addition to prevention, control and spatio-temporal sur-
veillance tools relevant to the understanding of schisto-
somiasis transmission dynamics, mapping of infectivity and
close monitoring of outbreaks are important [36,44-46].
Determinants of surveillance-response systems in
infectious diseases elimination
Surveillance and response represent the final, crucial steps
in achieving effective elimination of a disease (i.e. interrup-
tion of local transmission), as recognised in many of the on-
going malaria and NTD elimination programmes [47-49].
Introducing surveillance-response approaches characterise a
paradigm shift in maintaining comprehensive monitoring
and evaluation (M&E) activities towards focusing on the ap-
proaches that rapidly detect the remaining or re-emerging
pockets or hotspots of transmission and allow swift public
health action with adapted, integrated response packages to
interrupt transmission. The key feature of effective
surveillance-response systems should be based on the con-
cept of collecting a minimal essential set of data to identify
pockets of transmission, finding areas prone for re-
emergence, establishment of a strategic role in long-term
certification of elimination as well as an eye on potential
resurgence of new cases and/or outbreaks. Hence,
surveillance-response systems are distinctively differ-
ent from “classical” M&E that aims at collecting all
possible data/indicators that often leads to informationoverflow and little or delayed feedback of programme
control operations to elimination programmes man-
agement, and hence absence of rapid effective public
health action.
Passive and active surveillance systems have been utilised
for different purposes and at different stages of disease
control and elimination (Table 2). Passive surveillance
often gathers data from all available reporting systems,
aiming at reducing the public health burden in areas of
high endemicity. The information from passive surveillance
is used for setting sentinel sites for parasites, vectors and
intermediate hosts, resistance monitoring, defining the
geographical distribution of parasitic diseases and evaluat-
ing or synthesising the control or elimination programmes
to respond to a particular target, for instance, M&E of the
Global Fund to Fight AIDS, Tuberculosis and Malaria
(http://www.theglobalfund.org/en/) [50,51]. Active surveil-
lance places special emphasis on finding cases in the com-
munity mainly through door-to-door surveys, or gathering
of information from institutions and healthcare providers.
For example, to identify immigrants infected with P. fal-
ciparum, a dry-season, breeding-site mapping and an
epidemiological survey were conducted, followed by
diagnosis of malaria patients in the community and
treatment in combination with integrated vector
management (e.g. indoor residual spraying (IRS) and long-
lasting insecticidal net (LLIN) campaigns). In addition, in
their move towards elimination of the vicious cycle of pov-
erty and infectious diseases, malaria consortia should con-
tinuously provide technical assistance for health system
strengthening and the development of innovative tools to
improve malaria surveillance and provide national and dis-
trict staff with the information they need to respond to
malaria outbreaks as well as to individual cases [50,52-54].
The Forum elaborated on a set of effective and essen-
tial features to achieve infectious disease elimination,
Table 2 Key definitions of some common terms
Term Definition
Classical definition of surveillance Ongoing systematic collection, analysis and interpretation of data, usually incidence of cases of disease.
In the WHO Global Malaria Action Plan (GMAP), surveillance is defined as follows: “.... is aimed at discovery,
investigation, and elimination of continuing transmission, the prevention and cure of infection and final
substantiation of claimed eradication.”
Surveillance and response or surveillance
as an intervention
Aiming to reduce transmission through monitoring and evaluation (M&E), this activity requires a shift from
measuring morbidity and mortality to detecting infections and measuring transmission using novel,
field-ready tools and strategies for the active detection of asymptomatic infection. It may include
DNA-based and/or serological biomarkers, new effective approaches tracking population dynamics,
effective field-based mapping linked to databases, improved measurements of mapping transmission
and improve the feasibility, efficiency and cost-effectiveness of new health information systems.
Active surveillance A structure engaging health professional to frequently monitor health care providers or the population to
gather information about health situations. Although not cost-effective, active surveillance provides the
most accurate and timely information.
Passive surveillance A structure by which a health authority takes delivery of reports submitted from district to provincial
hospitals, clinics, public health units or other sources. It is a cost-effective approach covering most
populations, and offering critical information for monitoring a community’s health. However, due to its
dependency on data provision from different institutions or hospitals, the quality of data can be hard to
assess.
Sentinel surveillance A structure supported by a reporting system based on selected institutions or individuals that provide
regular, complete reports on one or more diseases occurring ideally in a defined catchment. It also
provides additional data on individual cases.
Integrated surveillance A combination of active and passive systems using a single organisation that collects information about
multiple diseases or behaviours of interest to several intervention programmes (e.g. health facility-based
system may continuously gather data that are linked to disease-specific data and quality control of the
information or on multiple infectious diseases and disorders.
Syndrome surveillance An active or passive system that uses case definitions that are based entirely on clinical features without
any clinical or laboratory diagnosis. It is inexpensive and is faster than systems that require laboratory
confirmation mostly applied in developing countries but lack of specificity (subjective) and require further
analysis.
Control The reduction of disease incidence, prevalence, morbidity or mortality to a locally acceptable level as a
result of deliberate efforts.
Elimination The reduction to zero of the incidence of infection in a defined geographical area as a result of deliberate
efforts and continued measures to prevent re-establishment of transmission are required.
Eradication The permanent reduction to zero of the worldwide incidence of infection, as a result of time-bound,
deliberate efforts. Once eradication has been achieved, intervention measures are no longer needed.
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commitment to use local resources for elimination activ-
ities; (iii) worthy organisational and technical infrastruc-
ture coupled with qualified and committed personnel;
(iv) adequate general health care services delivery; (v)
making communities understand and support the con-
trol programmes; (vi) no major uncontrolled population
movements; and (vii) P. vivax and P. falciparum malaria
addressed based on WHO’s global roadmap.
A paradigm shift towards elimination
The move from morbidity control to interruption of
transmission and achievement of elimination requires
novel, advanced technologies, either aimed at reducing
the infection reservoir or at reducing the rate at which
infections spread. This can be done by an innovative re-
search portfolio that is expanded to include NTDs, zoo-
noses and other socioeconomic determinants in most
endemic countries, particularly in sub-Saharan Africa. Im-
portant outcomes from the First Forum on Surveillance-Response System Leading to Tropical Diseases Elimin-
ation include foremost important lessons from previous
outbreaks and resurgences of parasitic diseases in China
and elsewhere; second, new surveillance-response plat-
forms capable of further strengthening existing health sys-
tems at all levels; third, long-term commitment, which is
crucial to achieve sustainability of the elimination agenda;
fourth, political will, i.e. commitment to use local re-
sources and implementation of innovative multi-sectoral,
integrated approaches; fifth, improved diagnostic tools for
early detection of infection and disease; and finally, but not
the least, capacity-building, new partnerships and use of in-
novative technology to render existing surveillance-response
systems more effective [17,19,23,29,32,36,46,50,52,55].
The following questions were raised: (i) Do we have,
and are we using, the most effective surveillance tools
(this is of particular relevance with regard to diagnostics)?
(ii) Are we implementing the most effective surveillance-
response packages tailored to a given transmission setting?
(iii) Is it possible to innovate and incorporate additional
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are the contributions of private companies to health? (v)
How can we be sure that we move in the right direction?
The Forum promptly progressed to addressing these ques-
tions during different sessions.
The way forward and recommendations
Participants felt that the Forum provided a stimulating
environment for exchange of ideas and experiences giv-
ing an impetus for rapid progress towards surveillance
and response systems in elimination of tropical diseases
that impact on the health and well-being of disadvantaged
and marginalised populations in the world. It was con-
cluded that the Forum should be held every 2 years. Hence,
at the time of writing the current report, planning for the
June 2014 forum is intensifying. The following recommen-
dations for strengthening research on surveillance-response
systems for disease elimination were put forward.
Establishment of a resource-sharing platform for effective
surveillance-response systems
The Forum recognised that containing the emergence
and spread of tropical diseases requires early alertness,
active detection and diagnosis of its pathogenic cause.
Concerted efforts and effective partnerships are needed
to share the roles and responsibilities in defining power-
ful surveillance-response systems to mitigate the public
health burden of tropical diseases thereby ensuring scal-
ability and sustainability.
Setting up a genuine coordination and collaboration
between Asia Pacific and Africa with regard to public
health and control/elimination of malaria and NTDs was
encouraged, emphasising surveillance-response systems
that rely on an integrated and dynamic approach to risk
management with ongoing research, data collection and
real-time analysis, thereby driving evidence-informed
knowledge translation into policy decisions and action
with a feedback process to facilitate continuous ad-
vancement and adaptation.
Continuous scrutiny of all aspects of infectious diseases
occurrence and spread, pertinent to effective control and
elimination, requires systematic collection, collation, ana-
lysis, interpretation and dissemination of health data and
the establishment of a resource-sharing platform for
surveillance-response system between Asia Pacific and
Africa. Reconvening the Forum every 2 years would pro-
vide an opportunity to discuss progress and challenges in
implementing local, national or regional surveillance-
response system for targeted infectious diseases, discover-
ies and developments among scientists, public health
specialists, politicians and other stakeholders.
Importantly, documented limitations call for dispersion of
technological advances in most developing countries of Asia
Pacific and Africa, so that surveillance-response strategiesand rapid diagnostic methods, tools and approaches can be
improved. This requires continued innovation, valid-
ation and application of efficient, low-cost diagnostic,
affordable novel therapeutic agents and vaccines [4,5].
Development of new tools and strategies
Sensitive diagnostic tools based on molecular methods
and advanced biotechnological assays need to be devel-
oped as surveillance tools for monitoring and verifica-
tion of elimination of tropical diseases [19,39,52,56].
Clinical outcomes and standard operating procedures
for efficacy monitoring and safety assessment of drugs
against malaria and NTDs must be carefully re-evaluated
and cut-offs determined. In addition, in vitro sensitivity
limitations of currently deployed detection tools (e.g. mi-
croscopy and rapid diagnostic tests) have been docu-
mented, and hence, there is a need for improved tools
in assessing susceptibility [19,56].
The Forum provided a unique opportunity to discuss
surveillance-response systems as the final stage towards
elimination of infectious diseases, especially NTDs, based
on a “One World-One Health” perspective. Five research
priorities were recommended: (i) dynamic detection and
mapping of transmission, particularly low-level transmis-
sion, also using eHealth and mHealth; (ii) near real-time
monitoring of population dynamics; (iii) modelling to es-
tablish minimal essential databases and indicators to be
collected in space and time; (iv) design of effective re-
sponse packages tailored to different transmission settings
and levels; and (v) rigorous validation of approaches and
response packages with regards to effectiveness within
elimination programmes.
Certification of surveillance-response systems
It was emphasised that regional strategies, innovative data
management tools, inter-sectoral, multi-disease control
approaches and research framework on control and elim-
ination of infectious diseases of poverty must be strength-
ened [55]. Surveillance-response systems directed towards
elimination of malaria, schistosomiasis and other selected
NTDs should be focusing on research priorities, innova-
tive mechanisms, including tool development, targeting
verification and certification of elimination. The central
role that diagnostic tools play in certification of disease
elimination is imperative and rigorous surveillance tools
and data management are supportive in improving public
health surveillance and response systems for prevention
and control of priority-set diseases at all levels of national
health systems [57,58].
Transfer of Chinese experiences of surveillance-response
systems to endemic countries with limited resources
China can provide expert support on the establishment
of diagnostic tools and techniques, in providing capacity
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technicians, medical staff and disease control managers
in Africa. Moreover, support in monitoring techniques
and conducting collaborative research on all aspects of
effective surveillance-response mechanisms can be pro-
vided depending on context, nature of endemicity. As-
sistance can be provided to African countries to
complement their own electronic reporting system for
infectious diseases (e.g. malaria, schistosomiasis and other
selected NTDs), including continuous monitoring and
evaluation of disease transmission dynamics through in-
novative Sino-Africa partnership. China had developed ef-
fective surveillance and early warning systems (EWS) for
malaria and schistosomiasis based on electronic-based
reporting systems [45,59] and these resources can be
transferred to other endemic countries with limited re-
sources. China has successfully contained malaria re-
emergence in Anhui province since the 2006 update of
the situation [60]. Lessons learnt facilitate monitoring of
focal prevalence, while modelling of changing transmis-
sion factors and trends prediction produce better tactics
as well as strategic evidence not only for policy support,
but also for direction, planning and implementation of
pilot surveillance -response systems sites with respect to
control/elimination.
It is worth noting that China has made significant contri-
butions in the discovery and development of drugs against
malaria (e.g. artemisinins), schistosomiasis (e.g. artemisi-
nins and mefloquine) and soil-transmitted helminthiasis
(e.g. tribendimidine) [61-63]. The artemisinins have
been re-discovered by Chinese scientists in the late
1970s and combination therapy based on this drug (ACT)
is the recommended first-line treatment in most malaria-
endemic areas where multi-drug resistant P. falciparum
and P. vivax (chloroquine, mefloquine and sulphadoxine-
pyrimethamine) exist. Drug resistance is a very important
consideration in malaria control demanding the application
of approaches, such as real-time molecular genotyping of
sexual and asexual resistant biomarkers from asymptom-
atic and symptomatic population. This activity is para-
mount in endemic areas for the monitoring of emerging
trends of susceptibility and drug resistance, which are key
components of malaria control towards elimination.
Future global health involvements include the establish-
ment of comprehensive sites for M&E and impact assess-
ment in sentinel sites, focussing on three areas of possible
research-action programmes: (i) characterising how demo-
graphic, epidemiological and environmental factors influ-
ence disease transmission by comprehensive comparison of
population prevalence, capacity building in diagnostic abil-
ity, effects of integrated vector management between dem-
onstration areas and control areas; (ii) socioeconomic
factors and the status of prevailing health systems; and (iii)
strategy and measurement assessment, including evaluatingintervention effects of a related policy and strategy applied
in the interventional areas and further exploration of the
external validity of the findings from these areas.
The Forum reviewed the action plans of NTD control
and elimination articulated in the WHO roadmap and
China CDC, as well as the national schistosomiasis elim-
ination programme for China (2009-2015), placing par-
ticular emphasis on surveillance-response systems. China’s
challenges and needs in tropical disease control, and its
experiences and lessons learnt necessitate national govern-
ments to build and implement surveillance-response
systems to deal with tropical diseases, including imported
cases and new outbreaks.
The first Forum provided a platform for exchange
among participants from different countries and sectors
who presented their principles and approaches from dis-
ease control to elimination. The reader should, however,
be aware that the current report expresses the opinions
of the individuals participating in the Forum and does
not intend to be an exhaustive exploration of the subject
matter or a representation of consensus.
Review and conclusion
During the First Forum on Surveillance-Response Sys-
tem Leading to Tropical Diseases Elimination, a priority
research agenda within a ‘One Health-One World’ frame
of global health was developed, including: (i) the estab-
lishment of a platform for resource-sharing and effective
surveillance-response systems for Asia Pacific and Africa
with an initial focus on elimination of lymphatic filaria-
sis, malaria and schistosomiasis; (ii) development of new
strategies, tools and approaches, such as improved diag-
nostics and antimalarial therapies; (iii) rigorous validation
of surveillance-response systems; and (iv) designing pilot
studies to transfer Chinese experiences of successful
surveillance-response systems to endemic countries with
limited resources.
More than 100 scientists, disease control managers
and other stakeholders participated in the First Forum
on Surveillance-Response System Leading to Tropical
Diseases Elimination. It offered the opportunity for discus-
sions and exchange of ideas and opinions with emphasis on
disease elimination and the key role played by surveillance-
response systems. Strengths and limitations of national and
international strategies for elimination, prevailing strategies,
and novel approaches required for elimination, rely on
useful surveillance-response platforms. Funding chan-
nels should be explored to intensify research and de-
velopment of new, innovative and effective platforms.
Supporting Sino-Africa partnership for control of para-
sitic diseases will require taking initiatives for global
health and the best experiences from China and the
international community to Africa. New operational
research should be devoted to identify risk factors and
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spread of disease outbreak with enhanced geographical
information systems (GIS), health systems, care man-
agement and an integrated approach in improving the
efficiency of surveillance-response systems.
Sustained control can only be made leading to elimin-
ation by accelerating breakthroughs in research, while
fully understanding inputs, processes, outcomes and im-
pact on transmission. The launch of the WHO roadmap
perpetuates the need for effective surveillance-response
systems tailored to local settings. Systems effectiveness de-
pends on access to highly sensitive diagnostics, prompt
treatment and follow-up as well as quality of care and pa-
tient trust. Sensitive tools for surveillance for xenobiotic
monitoring and a deeper understanding of which tools
and strategies are most suitable to achieve elimination of
malaria, schistosomiasis and other NTDs are needed.
Moving from classical M&E to surveillance as an inter-
vention and interruption of transmission not only requires
high standards in data collection (minimal essential data-
bases in space and time) and appropriate analysis, but also
experiences in modelling and validation, verification of
elimination and reliable forecasting. Finally, relevant ef-
fective intervention science is a must in order to improve
the effectiveness of the policies recommended and the
public health interventions undertaken.Additional file
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